From 153 days to 100: the target the NHS has just met on clinical trials
What happened
On 21 October 2026 the Department of Health and Social Care said the government had met its target for setting up commercial clinical trials in the UK more quickly. A clinical trial is a carefully run study that tests whether a new treatment works and whether it is safe. "Set-up" means the time between a company deciding to run its trial here and the first patient actually being able to join. For years that wait in the UK was long. Long enough that some companies took their trials to other countries instead. The new figures cover the three months to March. In that period the average set-up time for a commercial trial was 100 days. A year earlier it had been 153 days. The department put the overall fall in delivery times at 35%. The target was for 95% of commercial trials to be set up within 150 days. All 24 trials in that period managed it, which is 100%. Approvals have sped up too. Every study that went through the joint MHRA and ethics committee route in September 2026 was approved within 60 days. The MHRA is the UK's medicines regulator. An ethics committee is an independent group that checks a study is fair to the people taking part.
Why this matters
If you or someone in your family has a serious illness, a trial is sometimes the only way to reach a treatment that is not yet on prescription. Every week of delay in setting up a study is a week in which nobody can join it. Speed also decides where trials happen at all. Drug companies run their studies in a handful of countries. If the UK is slow, we are simply skipped, and patients here never get the offer. Faster set-up makes the UK a more likely choice. There is a second benefit that is easy to miss. Hospitals that run research tend to be better at the everyday care around it, because staff stay close to the newest evidence. So the gain is not only for the small number of people in a study. Professor Frankie Swords, National Medical Director, said the aim is to make research more routinely available across the NHS, including in family doctor surgeries and neighbourhood care rather than only in big city hospitals. That would matter a great deal in counties like Lincolnshire, where the nearest large research centre can be a long drive away.
What the evidence actually says
The figures are real, but it is worth being careful about what they cover. First, they are about **commercial** trials, which are the ones paid for by companies. They do not describe every piece of research in the NHS. Second, they measure set-up, not results. A trial that opens in 100 days instead of 153 days still takes years to tell us whether a treatment works. Nothing in this announcement means a new medicine arrives sooner on your repeat prescription. Third, the sample for the headline number is small. Twenty-four trials in three months is not many, so the average can move about from quarter to quarter. The release gives some named examples. The CHILL study screened its first participant 113 days after entering set-up. The BEATRIX study, which is testing a group B strep vaccine for pregnant women, was set up in under 150 days. Moderna's Nova 301 study recruited 2,500 volunteers in nine weeks. Richard Torbett, chief executive of the industry body the ABPI, welcomed the progress but added a caution worth repeating: the gains have to turn into more patients actually taking part. Set-up speed and recruitment are not the same thing. Philippa Brown of GSK made a similar point, saying NHS sites need sustained resources to recruit more patients. In other words: a genuine step forward, openly reported, with the people involved saying plainly that the job is not finished.
Practical advice
You do not need to wait to be invited to a trial. You can look for yourself. **Start with Be Part of Research.** This is the NHS and NIHR service that lists studies looking for volunteers across the UK. You can search by condition and by how far you are willing to travel. It is free, and signing up does not commit you to anything. **Ask your own team.** Your GP, hospital consultant or specialist nurse may know of studies locally that are not easy to find online. A short question at your next appointment costs nothing: "Is there any research I could join for this?" **Ask the practical questions before you agree.** How many visits? Where, and how will I get there? Are travel costs covered? What happens if I want to stop? A good research team expects these questions and will answer them without pressure. **Remember you can leave at any time.** Taking part is voluntary, and stopping does not affect your normal NHS care. That is a rule, not a favour. **Do not stop your current medicines to qualify for anything.** Talk to your pharmacist or doctor first, always.
What to know
The government has met its target to speed up commercial clinical trial set-up in the UK. Average set-up fell from 153 days to 100 days, and all 24 commercial trials in the three months to March were set up inside 150 days. Approvals through the joint MHRA and ethics route all came within 60 days in September 2026. This makes the UK a more likely place for companies to run studies, which means more chances for patients here to be offered one. It does not mean new treatments reach ordinary prescriptions any faster, and the people involved say recruitment is the next hurdle. If you are living with a long-term or serious condition, the useful next step is small: search Be Part of Research, or simply ask your own clinician whether a study exists for you. Sources: GOV.UK (Department of Health and Social Care and Office for Life Sciences), "Faster clinical trials bring cutting-edge treatments to patients", 21 October 2026, https://www.gov.uk/government/news/faster-clinical-trials-bring-cutting-edge-treatments-to-patients. GOV.UK (MHRA), "MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicines", 14 October 2026, https://www.gov.uk/government/news/mhra-2030-strategy-to-modernise-patient-centred-regulation-for-the-era-of-ai-and-personalised-medicines. NIHR, "Be Part of Research", accessed 22 October 2026, https://bepartofresearch.nihr.ac.uk/. This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional.
Related articles
44% of over-75s are active, against 64% of 55 to 74s: the government replies
On 22 October 2026 the government published its formal reply to a report by the House of Commons Health and Social Care Committee. The committee's report is ca…
£9.4 million to move mental health workers into children's social care teams
On 23 October 2026 the government announced a new mental health pilot for children and young people who are supported by children's social care. The pilot is c…
One tablet a day: the UK has licensed a new psoriasis treatment
On 23 October 2026 the Medicines and Healthcare products Regulatory Agency (MHRA) licensed a new medicine for plaque psoriasis. The medicine is called icotroki…